|
1
|
Drossaers-Bakker KW, de Buck M, van Zeben
D, Zwinderman AH, Breedveld FC and Hazes JM: Long-term course and
outcome of functional capacity in rheumatoid arthritis: The effect
of disease activity and radiologic damage over time. Arthritis
Rheum. 42:1854–1860. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davignon JL, Hayder M, Baron M, Boyer JF,
Constantin A, Apparailly F, Poupot R and Cantagrel A: Targeting
monocytes/macrophages in the treatment of rheumatoid arthritis.
Rheumatology (Oxford). 52:590–598. 2013. View Article : Google Scholar
|
|
3
|
Gol-Ara M, Jadidi-Niaragh F, Sadria R,
Azizi G and Mirshafiey A: The role of different subsets of
regulatory T cells in immunopathogenesis of rheumatoid arthritis.
Arthritis. 2012:8058752012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brennan FM and McInnes IB: Evidence that
cytokines play a role in rheumatoid arthritis. J Clin Invest.
118:3537–3545. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bugatti S, Codullo V, Caporali R and
Montecucco C: B cells in rheumatoid arthritis. Autoimmun Rev.
7:137–142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leandro MJ, Cambridge G, Ehrenstein MR and
Edwards JC: Reconstitution of peripheral blood B cells after
depletion with rituximab in patients with rheumatoid arthritis.
Arthritis Rheum. 54:613–620. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mariette X, Rouanet S, Sibilia J, Combe B,
Le Loët X, Tebib J, Jourdan R and Dougados M: Evaluation of
low-dose rituximab for the retreatment of patients with active
rheumatoid arthritis: A non-inferiority randomised controlled
trial. Ann Rheum Dis. 73:1508–1514. 2014. View Article : Google Scholar
|
|
8
|
Reddy V, Croca S, Gerona D, De La Torre I,
Isenberg D, McDonald V, Leandro M and Cambridge G: Serum rituximab
levels and efficiency of B cell depletion: Differences between
patients with rheumatoid arthritis and systemic lupus
erythematosus. Rheumatology (Oxford). 52:951–952. 2013. View Article : Google Scholar
|
|
9
|
Bredemeier M, de Oliveira FK and Rocha CM:
Low-versus high-dose rituximab for rheumatoid arthritis: A
systematic review and meta-analysis. Arthritis Care Res (Hoboken).
66:228–235. 2014. View Article : Google Scholar
|
|
10
|
Goetz M, Atreya R, Ghalibafian M, Galle PR
and Neurath MF: Exacerbation of ulcerative colitis after rituximab
salvage therapy. Inflamm Bowel Dis. 13:1365–1368. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wolf SD, Dittel BN, Hardardottir F and
Janeway CA Jr: Experimental autoimmune encephalomyelitis induction
in genetically B cell-deficient mice. J Exp Med. 184:2271–2278.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mauri C, Gray D, Mushtaq N and Londei M:
Prevention of arthritis by interleukin 10-producing B cells. J Exp
Med. 197:489–501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Evans JG, Chavez-Rueda KA, Eddaoudi A,
Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR and Mauri C: Novel
suppressive function of transitional 2 B cells in experimental
arthritis. J Immunol. 178:7868–7878. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Neta R and Salvin SB: Specific suppression
of delayed hypersensitivity: The possible presence of a suppressor
B cell in the regulation of delayed hypersensitivity. J Immunol.
113:1716–1725. 1974.PubMed/NCBI
|
|
15
|
Yang M, Rui K, Wang S and Lu L: Regulatory
B cells in autoimmune diseases. Cell Mol Immunol. 10:122–132. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mauri C and Bosma A: Immune regulatory
function of B cells. Annu Rev Immunol. 30:221–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao
Z, Wang S, Hua Z, Sun L, Srivastava G, et al: IL-10-producing
regulatory B10 cells ameliorate collagen-induced arthritis via
suppressing Th17 cell generation. Am J Pathol. 180:2375–2385. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Braun J and Wei B: Regulatory B
cells in autoimmune diseases and mucosal immune homeostasis.
Autoimmunity. 44:58–68. 2011. View Article : Google Scholar
|
|
19
|
Matsushita T, Yanaba K, Bouaziz JD,
Fujimoto M and Tedder TF: Regulatory B cells inhibit EAE initiation
in mice while other B cells promote disease progression. J Clin
Invest. 118:3420–3430. 2008.PubMed/NCBI
|
|
20
|
Gray M, Miles K, Salter D, Gray D and
Savill J: Apoptotic cells protect mice from autoimmune inflammation
by the induction of regulatory B cells. Proc Natl Acad Sci USA.
104:14080–14085. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lemoine S, Morva A, Youinou P and Jamin C:
Regulatory B cells in autoimmune diseases: how do they work? Ann N
Y Acad Sci. 1173:260–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fillatreau S, Sweenie CH, McGeachy MJ,
Gray D and Anderton SM: B cells regulate autoimmunity by provision
of IL-10. Nat Immunol. 3:944–950. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yanaba K, Bouaziz JD, Haas KM, Poe JC,
Fujimoto M and Tedder TF: A regulatory B cell subset with a unique
CD1dhiCD5+ phenotype controls T cell-dependent inflammatory
responses. Immunity. 28:639–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zha B, Wang L, Liu X, Liu J, Chen Z, Xu J,
Sheng L, Li Y and Chu Y: Decrease in proportion of CD19+CD24(hi)
CD27+ B cells and impairment of their suppressive function in
Graves' disease. PLoS One. 7:e498352012. View Article : Google Scholar
|
|
25
|
Iwata Y, Matsushita T, Horikawa M, Dilillo
DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM,
Williams AD, et al: Characterization of a rare IL-10-competent
B-cell subset in humans that parallels mouse regulatory B10 cells.
Blood. 117:530–541. 2011. View Article : Google Scholar :
|
|
26
|
Blair PA, Noreña LY, Flores-Borja F,
Rawlings DJ, Isenberg DA, Ehrenstein MR and Mauri C:
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in
healthy individuals but are functionally impaired in systemic Lupus
Erythematosus patients. Immunity. 32:129–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Newell KA, Asare A, Kirk AD, Gisler TD,
Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I,
Lechler RI, et al: Identification of a B cell signature associated
with renal transplant tolerance in humans. J Clin Invest.
120:1836–1847. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Zhong H, Bao W, Boulad N,
Evangelista J, Haider MA, Bussel J and Yazdanbakhsh K: Defective
regulatory B-cell compartment in patients with immune
thrombocytopenia. Blood. 120:3318–3325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arnett FC1, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American Rheumatism Association 1987 revised criteria
for the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wells GA, Tugwell P, Kraag GR, Baker PR,
Groh J and Redelmeier DA: Minimum important difference between
patients with rheumatoid arthritis: the patient's perspective. J
Rheumatol. 20:557–560. 1993.PubMed/NCBI
|
|
31
|
Hughes-Austin JM, Deane KD, Derber LA,
Kolfenbach JR, Zerbe GO, Sokolove J, Lahey LJ, Weisman MH, Buckner
JH, Mikuls TR, et al: Multiple cytokines and chemokines are
associated with rheumatoid arthritis-related autoimmunity in
first-degree relatives without rheumatoid arthritis: Studies of the
Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis.
72:901–907. 2013. View Article : Google Scholar :
|
|
32
|
Wilde B, Thewissen M, Damoiseaux J,
Knippenberg S, Hilhorst M, van Paassen P, Witzke O and Cohen
Tervaert JW: Regulatory B cells in ANCA-associated vasculitis. Ann
Rheum Dis. 72:1416–1419. 2013. View Article : Google Scholar : PubMed/NCBI
|
